For the year (end-31 December), Median saw revenues of 13.5 million euros, up 51% compared with revenues of 9 million euros in 2019. The company said that it was a record year for its iCRO business unit, a contract research organization (CRO) that provides services for oncology clinical trials.

The company also reported a strong fourth quarter, with revenues of 4.1 million euros, a 56% increase compared to revenue in the fourth quarter of 2019. At the end of the year, the company's backlog stood at 51.7 million euros, a 35% increase compared with 38.3 million euros at the same point at the end of 2019.